- Home
- NVAX vs DNUT Comparison
NVAX vs DNUT Comparison
Compare NVAX & DNUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- DNUT
- Stock Information
- Founded
- NVAX 1987
- DNUT 1937
- Country
- NVAX United States
- DNUT United States
- Employees
- NVAX N/A
- DNUT N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- DNUT Food Chains
- Sector
- NVAX Health Care
- DNUT Consumer Staples
- Exchange
- NVAX Nasdaq
- DNUT Nasdaq
- Market Cap
- NVAX 1.3B
- DNUT 505.6M
- IPO Year
- NVAX 1995
- DNUT 2021
- Fundamental
- Price
- NVAX $6.79
- DNUT $3.08
- Analyst Decision
- NVAX Buy
- DNUT Buy
- Analyst Count
- NVAX 5
- DNUT 8
- Target Price
- NVAX $16.60
- DNUT $9.73
- AVG Volume (30 Days)
- NVAX 4.7M
- DNUT 4.0M
- Earning Date
- NVAX 08-07-2025
- DNUT 08-07-2025
- Dividend Yield
- NVAX N/A
- DNUT 4.54%
- EPS Growth
- NVAX N/A
- DNUT N/A
- EPS
- NVAX 2.97
- DNUT N/A
- Revenue
- NVAX $1,254,962,000.00
- DNUT $1,597,883,000.00
- Revenue This Year
- NVAX $55.39
- DNUT N/A
- Revenue Next Year
- NVAX N/A
- DNUT $2.37
- P/E Ratio
- NVAX $2.31
- DNUT N/A
- Revenue Growth
- NVAX 25.92
- DNUT N/A
- 52 Week Low
- NVAX $5.01
- DNUT $2.50
- 52 Week High
- NVAX $17.81
- DNUT $12.68
- Technical
- Relative Strength Index (RSI)
- NVAX 53.90
- DNUT 49.49
- Support Level
- NVAX $6.75
- DNUT $3.22
- Resistance Level
- NVAX $7.20
- DNUT $3.47
- Average True Range (ATR)
- NVAX 0.28
- DNUT 0.20
- MACD
- NVAX 0.05
- DNUT 0.04
- Stochastic Oscillator
- NVAX 77.32
- DNUT 58.12
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
About DNUT Krispy Kreme Inc.
Krispy Kreme Inc is a sweet treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations across the globe. It derives maximum revenue from the U.S. segment.